UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Trial of Carboplatin Versus Radiotherapy for Stage I Seminoma: Mature Results on Relapse and Contralateral Testis Cancer Rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214)

Journal of clinical oncology, 2011-03, Vol.29 (8), p.957-962

2011

Volltextzugriff (PDF)

Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations

Neoplasia (New York, N.Y.), 2009-02, Vol.11 (2), p.102-125

2009

Volltextzugriff (PDF)

Use of CA-125 to Assess Response to New Agents in Ovarian Cancer Trials

Journal of clinical oncology, 2003-05, Vol.21 (10 suppl), p.187s-193

Rustin, Gordon J S

2003

Volltextzugriff (PDF)

Current controversies in the management of germ cell ovarian tumours

Current opinion in oncology, 2013-09, Vol.25 (5), p.539-545

2013

Volltextzugriff (PDF)

Phase I Clinical Trial of Weekly Combretastatin A4 Phosphate: Clinical and Pharmacokinetic Results

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2815-2822

2003

Volltextzugriff (PDF)

Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2831-2842

2003

Volltextzugriff (PDF)

Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer

International journal of gynecological cancer, 2017-07, Vol.27 (6), p.1118-1122

2017

Volltextzugriff (PDF)

The cost of surveillance following treatment of ovarian cancer

Gynecologic oncology, 2013-12, Vol.131 (3), p.501-502

Rustin, Gordon J.S

2013

Volltextzugriff (PDF)

Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment

Journal of clinical oncology, 2006-10, Vol.24 (30), p.4862-4866

2006

Volltextzugriff (PDF)

Pathological findings after primary chemotherapy in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection for advanced germ cell tumours

BJU international, 2013-04, Vol.111 (4b), p.E152-E157

2013

Volltextzugriff (PDF)

Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels

Journal of clinical oncology, 2001-10, Vol.19 (20), p.4054-4057

2001

Volltextzugriff (PDF)

Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel Versus Cisplatin and Cyclophosphamide

Journal of clinical oncology, 2006-01, Vol.24 (1), p.45-51

2006

Volltextzugriff (PDF)

Effects of 5,6-Dimethylxanthenone-4-Acetic Acid on Human Tumor Microcirculation Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Journal of clinical oncology, 2002-09, Vol.20 (18), p.3826-3840

2002

Volltextzugriff (PDF)

First-line therapy for ovarian cancer with carboplatin followed by paclitaxel–gemcitabine (SCOTROC5): A feasibility study and comparative analysis of the SCOTROC series

European journal of cancer (1990), 2010-07, Vol.46 (11), p.2020-2026

2010

Volltextzugriff (PDF)

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

The Lancet (British edition), 2010-10, Vol.376 (9747), p.1155-1163

2010

Volltextzugriff (PDF)

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet (British edition), 2016-03, Vol.387 (10023), p.1066-1074

2016

Volltextzugriff (PDF)

Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer

Clinical cancer research, 2012-06, Vol.18 (12), p.3428-3439

2012

Volltextzugriff (PDF)

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

Journal of clinical oncology, 2022-08, Vol.40 (22), p.2468-2478

2022

Volltextzugriff (PDF)

Comparison of Standard and CA-125 Response Criteria in Patients With Epithelial Ovarian Cancer Treated With Platinum or Paclitaxel

Journal of clinical oncology, 1999-02, Vol.17 (2), p.501-508

1999

Volltextzugriff (PDF)

Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial

Gynecologic oncology, 2020-03, Vol.156 (3), p.545-551

2020

Volltextzugriff (PDF)

Circulating tumor markers in gynecological tumors

Current opinion in oncology, 1996-09, Vol.8 (5), p.426-431

Rustin, Gordon J.S

1996

Volltextzugriff (PDF)

Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors

Clinical cancer research, 2012-03, Vol.18 (5), p.1415-1425

2012

Volltextzugriff (PDF)

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)

JNCI : Journal of the National Cancer Institute, 2004-03, Vol.96 (6), p.487-488

2004

Volltextzugriff (PDF)

Inhibition of Carboplatin-Induced DNA Interstrand Cross-link Repair by Gemcitabine in Patients Receiving these Drugs for Platinum-Resistant Ovarian Cancer

Clinical cancer research, 2010-10, Vol.16 (19), p.4899-4905

2010

Volltextzugriff (PDF)

Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis

NMR in biomedicine, 2002-04, Vol.15 (2), p.132-142

2002

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(64)
Buchkapitel
(1)

Sprache

Englisch
(65)

Erscheinungsjahr

n.n

Thema

Humans
(59)
Life Sciences & Biomedicine
(52)
Science & Technology
(52)
Female
(49)
Oncology
(39)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Adult
(27)
Chemotherapy
(20)
Middle Aged
(20)
Male
(19)
Treatment Outcome
(18)
Tumors
(18)
Pharmacology. Drug Treatments
(17)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Antineoplastic Agents
(13)
Gynecology. Andrology. Obstetrics
(13)
Ovarian Neoplasms - Drug Therapy
(13)
Ovarian Neoplasms - Therapy
(13)
Aged
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Trial of Carboplatin Versus Radiotherapy for Stage I Seminoma: Mature Results on Relapse and Contralateral Testis Cancer Rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214)

Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations

Use of CA-125 to Assess Response to New Agents in Ovarian Cancer Trials

Current controversies in the management of germ cell ovarian tumours

Phase I Clinical Trial of Weekly Combretastatin A4 Phosphate: Clinical and Pharmacokinetic Results

Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging

Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer

The cost of surveillance following treatment of ovarian cancer

Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment

Pathological findings after primary chemotherapy in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection for advanced germ cell tumours

Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels

Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel Versus Cisplatin and Cyclophosphamide

Effects of 5,6-Dimethylxanthenone-4-Acetic Acid on Human Tumor Microcirculation Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging

First-line therapy for ovarian cancer with carboplatin followed by paclitaxel–gemcitabine (SCOTROC5): A feasibility study and comparative analysis of the SCOTROC series

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

Comparison of Standard and CA-125 Response Criteria in Patients With Epithelial Ovarian Cancer Treated With Platinum or Paclitaxel

Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial

Circulating tumor markers in gynecological tumors

Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)

Inhibition of Carboplatin-Induced DNA Interstrand Cross-link Repair by Gemcitabine in Patients Receiving these Drugs for Platinum-Resistant Ovarian Cancer

Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis

Suchergebnisse filtern